Bedfont® Scientific Ltd and Aerosol Medical Systems partner, expanding access to FeNO testing in

MAIDSTONE, U.K. - EntSun -- Bedfont^® Scientific Limited, a world leader in breath analysis with nearly 50 years of expertise in the medical breath analysis industry, has formed a strategic partnership with Aerosol Medical Systems to improve Fractional exhaled Nitric Oxide (FeNO) testing accessibility in Latin America. Aerosol Medical Systems is an established leader in the field of respiratory therapy, providing a comprehensive service to improve quality of life.

"We are committed to diagnosing and treating respiratory diseases and have completed, in collaboration with Bedfont^®, the registration of the NObreath^® device with the healthcare authorities in Mexico." Comments Rodrigo León Molina, Director General and CEO at Aerosol Medical Systems. "The registration provides healthcare professionals with more accurate diagnostic tools and offers better treatment options for patients with asthma. This represents significant growth in the Mexican market, and will allow a larger number of tests to identify asthma early and better control the disease."

More on EntSun News

• U.S. Military to Benefit from Drone Tech Agreement with NovaSpark Energy, Plus Longer NASA Space Missions via Solar Power Leader: Ascent Solar $ASTI
• Karina Taylor Emerges as Manchester's Premier Personal Stylist
• It's a Naughty Christmas featuring Two Brothers One Mind and Special Guest
• $76 Million in Gold & Silver Holdings and Expanding Production — Pioneering the Future of Gold: Asia Broadband Inc. (Stock Symbol: AABB) is Surging
• Wohler announces three SRT monitoring enhancements for its iVAM2-MPEG monitor and the addition of front panel PID selection of A/V/subtitle streams

In 2019, a report found that in Mexico, 1,655 people died from asthma¹, highlighting the need for better asthma care across the region. The successful registration for the NObreath^® FeNO device in Mexico is a vital step to improving the accessibility of innovative diagnostic and management tools for asthma care.

"Our mission has always been to provide cutting-edge medical devices at affordable prices to improve accessibility and healthcare standards worldwide." Said Jason Smith, CEO at Bedfont^®. "By collaborating with Aerosol Medical Systems, we're helping clinicians across Mexico deliver faster, more personalised asthma care, empowering patients to live healthier lives."

Working on a foundation of shared values, including providing exceptional service, this partnership aims to improve asthma care in Mexico by ensuring that those living with this respiratory condition have access to instant, non-invasive, and simple breath testing to aid diagnosis and management.

More on EntSun News

• Schemawriter.ai launches WordPress plugin as industry leaders confirm - schema markup is critical
• 20 Million Financing to Accelerate Growth and Advance Digital Asset Strategy Secured for Super League (N A S D A Q: SLE)
• uCAR Trading Launches goldsilbermarkt.de, a New Online Shop for Precious Metals
• Webinar Announcement: Reputational Risk Management in Internal Investigations: Controlling the Narrative Before, During, and After a Crisis
• FMFW: Florida Men's Fashion Week Returns for its Third Season in Miami, November 15-16, 2025

To learn more about the NObreath^®, visit the website here (https://www.nobreathfeno.com/).

References

1.Lopez-Bago A, Lascurain R, Hernandez-Carreño PE, Gallardo-Vera F, Argueta-Donohue J, Jimenez-Trejo F, et al. Sex, Age, and Regional Disparities in the Burden of Asthma in Mexico from 1990 to 2019: A Secondary Analysis of the Global Burden of Disease Study 2019. Sustainability [Internet]. 2023 Aug 20 [cited 2025 Oct 14];15(16):12599–9. Available from: https://www.mdpi.com/2071-1050/15/16/12599?